Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Tiny ‘neural dust’ sensors may help scientists monitor your nerves in real time

Add as a preferred source on Google

The burgeoning field of bioelectronic medicine has been buzzing recently with Google affiliate Verily (previously Google Life Sciences) and medical company GlaxoSmithKline joining forces in a $715 million deal to launch Galvani Bioelectronics. By tapping into our bodies’ natural electrical signals, these tiny, implantable devices have the potential to support a new class of therapies known as “electroceuticals.”

A team of engineers from UC Berkeley have made a breakthrough in the emerging field by creating tiny, wireless sensors they’ve called “ultrasonic neural dust,” which provide biometric information in real time. They say this is the first device of its kind to monitor neural activity in living animals. The minimally invasive devices may help treat disorders ranging from inflammation to epilepsy. A report detailing their study was published last week in the journal Neuron.

Recommended Videos

“This is the first time someone has used ultrasound as a method of powering and communicating with extremely small implantable systems,” one of the paper’s authors, Donjon Seo, told Scientific American. “This opens up a host of applications in terms of embodied telemetry: being able to put something super-tiny, super-deep in the body, which you can park next to a nerve, organ, muscle or gastrointestinal tract, and read data out wirelessly.”

NeuralDust
Ryan Neely
Ryan Neely

To test the “neural dust,” the researchers implanted them into the muscles and surrounding nerves of rats, and transmitted ultrasound to the implanted devices, which returned information about the nerves’ electrical signals. Ultrasound also provides a power source, enabling the researchers to get rid of batteries and wires. And, although not unnoticeable in rats, the sand-grain-sized devices would be exceptionally small in humans.

“The original goal of the neural dust project was to imagine the next generation of brain-machine interfaces, and to make it a viable clinical technology,” neuroscience graduate student Ryan Neely said in a press release. “If a paraplegic wants to control a computer or a robotic arm, you would just implant this electrode in the brain and it would last essentially a lifetime.”

In the future, the engineers hope to design the device so that it can be implanted in the brain and detect non-electrical signals, including data on oxygen and hormone levels.

Dyllan Furness
Former Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more